Tiansheng Pharmaceuticals acquired a 100% stake in the controlling company of 30.96 million

Tiansheng Pharmaceuticals announced on the evening of December 12 that it had acquired a 100% stake in Chongqing Datron Electrical and Mechanical Equipment Co., Ltd. (hereinafter referred to as Dasheng Electrical and Mechanical) for 30.96 million yuan.
"Daily Economic News" reporter noted that Tiansheng Pharmaceuticals since the listing in May this year has carried out a series of investment and acquisition operations, and the acquisition of Datron Electrical and Mechanical has not yet carried out business activities. However, the announcement said: the acquisition of Datron electrical and mechanical is conducive to the company's long-term development, improve the company's normative operation. Reporters on the relevant questions to call the company's secretary-general, the other staff said they could not answer the relevant questions.after the listing of investment action continued
Tiansan Pharmaceutical landed on the Shenzhen Stock Exchange in May this year, the company is in the pharmaceutical industry, mainly engaged in pharmaceutical manufacturing and pharmaceutical circulation, the scope of business covers pharmaceutical manufacturing, pharmaceutical circulation, Chinese herbal medicine cultivation and processing, drug research and development and other fields.
the company went public, Tiansheng Pharmaceuticals began a series of investments and acquisitions. On June 14, the company issued two foreign investment announcements: the company plans to build Tiansin Pharmaceutical Group's Chinese herbal medicine industrialization project in Chaoyang Street Chaoyang Street, Zhengyang Industrial Park, Chongqing City, with a total investment of 150 million yuan, and another is proposed by Chongqing Changtian Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, to build a chemical raw material GMP construction project in Chongqing Longevity Economic and Technological Development Zone, with a total investment of 260 million yuan.
August 11, the company announced that it intends to acquire 5.1 million shares of Hubei Xianming Medical Devices Co., Ltd. with its own capital of 5.1 million shares, the company will hold 51% of its shares;
immediately after October 19, the company announced that it intends to invest 14.6 million yuan in cash from Chongqing Guangyao Photoelectrical Technology Co., Ltd. to obtain 20% of its shares, funded by the company's own funds. The announcement said that the project belongs to the field of health lighting, and the company's main business belongs to the large health industry.
However, industry and commerce data show that until September 8 this year, Chongqing Guangyao Photoelectronics Technology Co., Ltd. has added "medical technology, biotechnology research and development, technology transfer" and other business scope, the previous scope of its business is "technology development, technical advice, technology transfer, technology services;acquisition of the controlling company
, after a series of acquisitions, the company announced on the evening of December 12th that it had acquired a 100% stake in Datron Electrical and Mechanical Group for 30.96 million yuan.
reporters understand that Changlong Group and Tiansheng Pharmaceuticals belong to the same actual controller Mr. Liu Qun controlled enterprises, so this transaction is related transactions.
data show that the scope of business for the production and sale of datron electrical and mechanical: central air conditioning, medical device research and development, biological products research and development and technical advice, but the company has not yet carried out the above-mentioned business activities.
According to the "Audit Report" No. 381 issued by Sichuan Huaxin (Group) accounting firm, as of October 31, 2017, the total assets of Daxin Electrical and Mechanical Services were RMB62.4798 million and the net assets were RMB28,084.7 million;
said that the acquisition of Datron electrical and mechanical is conducive to the company's long-term development, improve the company's standard operating level.
from the content presented in the announcement, the target company has not so far carried out business activities within the scope of the company's operations. So, how is this acquisition conducive to the long-term development of the company? Reporters on this question called the company's secretary-general, the other staff said they could not answer the relevant questions. (Daily Economic News)